AI coach helps oral cancer patients move again
NCT ID NCT07635381
First seen Jun 26, 2026 · Last updated Jul 21, 2026 · Updated 3 times
Summary
This study tests whether an AI-powered physiotherapy system can help oral cancer patients improve mouth, neck, and shoulder movement after surgery or radiation. Fifteen participants will use the system for 4 to 6 weeks, doing daily exercises prescribed by the AI. The goal is to see if the approach is feasible, safe, and acceptable before larger trials.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- AI-assisted physiotherapy
- What this could lead to
- If successful, this could provide a personalized, home-based exercise program to help oral cancer survivors regain jaw, neck, and shoulder movement.
- What could go wrong
- This is a very small, early feasibility study with only 15 participants and no control group. The AI system may not be user-friendly or effective for everyone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AI (ARTIFICIAL INTELLIGENCE) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
School and Graduate Institute of Physical Therapy, College of Medicine, National Taiwan University
Taipei, 100, Taiwan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a glowing drug light up head and neck tumors?
- Can a single tracer light up cancer's first stop? a trial puts a hybrid dye-and-radioactive marker to the test.
- New tracheostomy tube holder aims to cut infections and boost comfort
- HIV and cancer: study seeks to uncover hidden risk factors
- New drug combo targets HPV-Driven cancers in phase II trial
- Could an immunotherapy combo replace harsh chemo for head and neck cancer?